|4Feb 8, 4:48 PM ET

ASADORIAN RAFFI 4

4 · ACELRX PHARMACEUTICALS INC · Filed Feb 8, 2023

Insider Transaction Report

Form 4
Period: 2023-02-06
ASADORIAN RAFFI
Chief Financial Officer
Transactions
  • Tax Payment

    Common Stock

    2023-02-06$2.02/sh617$1,24617,589 total
Footnotes (3)
  • [F1]Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.
  • [F2]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
  • [F3]Reflects a 1-20 reverse stock split which became effective on October 25, 2022.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION